Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft
2007

Tyr66 as a Switch in SHP-2 Function

publication Evidence: moderate

Author Information

Author(s): Guvench Olgun, Qu Cheng-Kui, MacKerell Alexander D Jr

Primary Institution: University of Maryland School of Pharmacy

Hypothesis

Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft.

Conclusion

Tyr66 and surrounding residues play a regulatory role in SHP-2 function, and mutations at these sites can negatively impact pY-peptide binding.

Supporting Evidence

  • Mutations at Tyr66, Asp40, Lys55, and Gln57 are predicted to disrupt the switching mechanism.
  • The study suggests that the open cleft conformation is thermodynamically more favorable when N-SH2 is not bound to PTP.
  • Molecular dynamics simulations indicate that transitions between conformations are not diffusion controlled.

Takeaway

Tyr66 is like a switch that can open or close a door in a protein, helping it to do its job better or worse depending on its shape.

Methodology

Explicit-solvent molecular dynamics simulations were used to study the closed-to-open transition of the N-SH2 pY-peptide binding cleft.

Limitations

The study primarily focuses on molecular dynamics simulations, which may not capture all biological complexities.

Digital Object Identifier (DOI)

10.1186/1472-6807-7-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication